Biotechnology News
Source: Google
Biotechnology News
Yantai Zhenghai Biotechnology Third Quarter
Yantai Zhenghai Biotechnology Third Quarter 2024 Earnings: EPS: CN¥0.21 (vs CN¥0.21 in 3Q 2023) Simply Wall St
Posted on 23 October 2024 | 4:01 pm
News | Biotech landlords turn to higher end
News | Biotech landlords turn to higher end real estate as life science demand wanes CoStar Group
Posted on 23 October 2024 | 12:49 pm
Merck & Co buys Modifi Biosciences - The
Merck & Co buys Modifi Biosciences The Pharma Letter
Posted on 23 October 2024 | 10:28 am
Biotechnology And Pharmaceutical Services
Biotechnology And Pharmaceutical Services Outsourcing Market Size to Surpass USD 83.28 Bn by 2034 BioSpace
Posted on 23 October 2024 | 9:20 am
Editas Medicine changes strategy for lead
Editas Medicine changes strategy for lead CRISPR program The Pharma Letter
Posted on 23 October 2024 | 8:45 am
Source: Yahoo
Biotechnology News
Duhn Therapeutics inks license deal with OM
Duhn Therapeutics inks license deal with OM Pharma | Biotechnology | The Pharmaletter The Pharma Letter
Posted on 23 October 2024 | 6:52 am
‘In Vitro’ – First Look at Australian
‘In Vitro’ – First Look at Australian Horror Movie Tackling Biotechnology Experiments Bloody Disgusting
Posted on 23 October 2024 | 6:51 am
AvenCell raises $112 million in Series B
AvenCell raises $112 million in Series B financing The Pharma Letter
Posted on 23 October 2024 | 6:20 am
Sangamo shares jump as FDA clears faster
Sangamo shares jump as FDA clears faster gene therapy pathway The Pharma Letter
Posted on 23 October 2024 | 4:00 am
Alphina Therapeutics Appoints Veteran
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer Morningstar
Posted on 23 October 2024 | 4:00 am
Source: Bing
Biotechnology News
Genenta’s CEO to present at the U.S.
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” Morningstar
Posted on 23 October 2024 | 4:00 am
Genenta’s CEO to present at the U.S.
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” StockTitan
Posted on 23 October 2024 | 4:00 am
Indonesian approval for SK bioscience’s
Indonesian approval for SK bioscience’s SKYCellflu The Pharma Letter
Posted on 23 October 2024 | 3:49 am
GMOs could reboot chestnut trees - MIT
GMOs could reboot chestnut trees MIT Technology Review
Posted on 23 October 2024 | 3:22 am
Roche leaves Alzheimer partnership with UCB
Roche leaves Alzheimer partnership with UCB European Biotechnology News
Posted on 23 October 2024 | 2:33 am